Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
| ▸ | PPARD | Q03181 | 3/20 | 0.36 |
| ▸ | PPARA | Q07869 | 3/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2027940 | 0.84 | PPARA (0.52) | PPARGPPARDPPARA | |
| SCHEMBL24884149 | 0.81 | PPARG (0.34) | PPARGPPARDPPARAADRB2ADRB1 | |
| SCHEMBL28931138 | 0.81 | PPARA (0.41) | PPARGPPARDPPARAMMP12MMP13 | |
| SCHEMBL23158203 | 0.77 | PPARA (0.46) | PPARGPPARDPPARAADRB2ADRB1 | |
| SCHEMBL23143284 | 0.77 | PPARA (0.46) | PPARGPPARDPPARAADRB2ADRB1 | |
| SCHEMBL23143285 | 0.77 | PPARA (0.46) | PPARGPPARDPPARAADRB2ADRB1 | |
| SCHEMBL3513892 | 0.75 | PPARD (0.47) | PPARGPPARDPPARA | |
| SCHEMBL23871017 | 0.74 | PPARA (0.46) | PPARGPPARDPPARAHTT | |
| SCHEMBL23871140 | 0.74 | PPARA (0.46) | PPARGPPARDPPARAHTT | |
| SCHEMBL2030587 | 0.71 | PPARA (0.51) | PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022189856-A9 | COMPOUNDS USEFUL FOR TREATING LIVER DISEASES | ABIONYX PHARMA SA (FR) | 2022-10-13 | — | — | WO | disclosed |